Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Drugs
Published in: Drugs 2/2016

01-02-2016 | Current Opinion

Antidepressant Drugs for Postsurgical Pain: Current Status and Future Directions

Author: Ian Gilron

Published in: Drugs | Issue 2/2016

Login to get access

Abstract

Current treatments for postsurgical pain are often inadequate and adverse effects are substantial such that residual pain and/or side effects impair recovery. The recognition of analgesic efficacy with antidepressant drugs for chronic pain suggests the potential for efficacy in acute postsurgical pain. As reviewed here, current evidence suggests that approximately half of previous trials suggest efficacy of various antidepressants for acute postoperative pain. However, most trials are older with deficiencies including: lack of designation of a primary outcome, no assessment of movement-evoked pain, small size and limited safety assessment. Only one of three trials addressing prevention of chronic postsurgical pain suggested any efficacy; however, the evidence base for this indication is limited. Thus, current evidence does not yet support routine use of any one specific antidepressant for treatment of acute, or prevention of chronic, postsurgical pain. However, limitations in available trials are such that one cannot yet rule out the possibility that one or more antidepressant drugs may provide benefit in specific populations. Therefore, future larger trials should explore optimal dosing and duration of antidepressant treatment, procedure specificity, safety evaluation, and assessment of movement-evoked pain.
Literature
1.
Webb HE, Lascelles RG. Treatment of facial and head pain associated with depression. Lancet. 1962;1(7225):355–6.CrossRefPubMed
2.
Kuipers RK. Imipramine in the treatment of rheumatic patients. Acta Rheumatol Scand. 1962;8:45–51.PubMed
3.
Watson CP, Evans RJ, Reed K, Merskey H, Goldsmith L, Warsh J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology. 1982;32(6):671–3.CrossRefPubMed
4.
Max MB, Gilron I. Antidepressants, muscle relaxants, and NMDA receptor antagonists. In: Loeser JD, Turk D, Chapman CR, Butler S, editors. Bonica’s management of pain, 3rd ed. Philadelphia: Williams & Wilkins; 2001.
5.
Watson CPN, Gilron I, Pollock B, Lipman AG, Smith M. Antidepressant analgesics. In: Koltzenburg M, McMahon S, editors. Textbook of pain, 6th ed. Philadelphia: Elsevier Press; 2013.
6.
Kehlet H, Dahl JB. Anaesthesia, surgery, and challenges in postoperative recovery. Lancet. 2003;362:1921–8.CrossRefPubMed
7.
8.
Wheeler M, Oderda GM, Ashburn MA, Lipman AG. Adverse events associated with postoperative opioid analgesia: a systematic review. J Pain. 2002;3:159–80.CrossRefPubMed
9.
Neal JM, Bernards CM, Hadzic A, Hebl JR, Hogan QH, Horlocker TT, Lee LA, Rathmell JP, Sorenson EJ, Suresh S, Wedel DJ. ASRA practice advisory on neurologic complications in regional anesthesia and pain medicine. Reg Anesth Pain Med. 2008;33:404–15.PubMedCentralCrossRefPubMed
10.
Kenny GN. Potential renal, haematological and allergic adverse effects associated with nonsteroidal anti-inflammatory drugs. Drugs. 1992;44(Suppl 5):31–6.CrossRefPubMed
11.
Ceelie I, James LP, Gijsen V, Mathot RA, Ito S, Tesselaar CD, Tibboel D, Koren G, de Wildt SN. Acute liver failure after recommended doses of acetaminophen in patients with myopathies. Crit Care Med. 2011;39:678–82.
12.
Iorio ML, Cheerharan M, Kaufman SS, Reece-Stremtan S, Boyajian M. Acute liver failure following cleft palate repair: a case of therapeutic acetaminophen toxicity. Cleft Palate Craniofac J. 2013;38:437–9.
13.
Bell RF, Dahl JB, Moore RA, Kalso E. Perioperative ketamine for acute postoperative pain. Cochrane Database Syst Rev 2006;1:CD004603.
14.
Tiippana EM, Hamunen K, Kontinen VK, Kalso E. Do surgical patients benefit from perioperative gabapentin/pregabalin? A systematic review of efficacy and safety. Anesth Analg. 2007;104:1545–56.CrossRefPubMed
15.
Zhang J, Ho KY, Wang Y. Efficacy of pregabalin in acute postoperative pain: a meta-analysis. Br J Anaesth. 2011;106:454–62.CrossRefPubMed
16.
Straube S, Derry S, Moore RA, Wiffen PJ, McQuay HJ. Single dose oral gabapentin for established acute postoperative pain in adults. Cochrane Database Syst Rev 2010;5:CD008183.
17.
Gilron I. Clinical pharmacology of antidepressants and anticonvulsants for the management of pain. In: Tracey I, editor. Pain 2012—an updated review, Refresher Course Book. Washington: IASP Press, 2012.
18.
Micó JA, Ardid D, Berrocoso E, Eschalier A. Antidepressants and pain. Trends Pharmacol Sci. 2006;27(7):348–54.CrossRefPubMed
19.
Wong K, Phelan R, Kalso E, Galvin I, Goldstein D, Raja S, Gilron I. Antidepressant drugs for prevention of acute and chronic postsurgical pain: early evidence and recommended future directions. Anesthesiology. 2014;121(3):591–608.CrossRefPubMed
20.
Gordon NC, Heller PH, Gear RW, Levine JD. Temporal factors in the enhancement of morphine analgesia by desipramine. Pain. 1993;53:273–6.CrossRefPubMed
21.
Kerrick JM, Fine PG, Lipman AG, Love G. Low-dose amitriptyline as an adjunct to opioids for postoperative orthopedic pain: A placebo-controlled trial. Pain. 1993;52:325–30.CrossRefPubMed
22.
Vahedi P, Salehpour F, Aghamohammadi D, Shimia M, Lotfinia I, Mohajernezhadfard Z, Vahedi Y. Single dose preemptive amitriptyline reduces postoperative neuropathic pain after lumbar laminectomy and discectomy. Neurosurg Q. 2010;20:151–8.
23.
Porter EJB, Rolfe M, McQuay HJ. Single dose comparison of bicifadine and placebo in postoperative pain. Curr Ther ResClin Exp. 1981;30:156–60.
24.
Wang RI, Johnson RP, Lee JC, Waite EM. The oral analgesic efficacy of bicifadine hydrochloride in postoperative pain. J Clin Pharmacol. 1982;22:160–3.CrossRefPubMed
25.
Levine JD, Gordon NC, Smith R, McBryde R. Desipramine enhances opiate postoperative analgesia. Pain. 1986;27:45–9.CrossRefPubMed
26.
Max MB, Zeigler D, Shoaf S, Craig E, Benjamin J, Li SH, Buzzanell C, Perez M, Ghosh B. Effects of a single oral dose of desipramine on postoperative morphine analgesia. J Pain Symptom Manage. 1992;7:454–62.CrossRefPubMed
27.
Ho KY, Tay W, Yeo MC, Liu H, Yeo SJ, Chia SL, Lo NN. Duloxetine reduces morphine requirements after knee replacement surgery. Brit J Anaesth. 2010;105(371–6):42.
28.
Gordon NC, Heller PH, Gear RW, Levine JD. Interactions between fluoxetine and opiate analgesia for postoperative dental pain. Pain. 1994;58:85–8.CrossRefPubMed
29.
McQuay HJ, Carroll D, Poppleton P, Summerfield RJ, Moore RA. Fluradoline and aspirin for orthopedic postoperative pain. Clin Pharmacol Ther. 1987;41:531–6.CrossRefPubMed
30.
Ceccherelli F, Diani M, Altafini L, Varotto E, Stefecius A, Casale R, Costola A, Giron G.P. Postoperative pain treated by intravenous l-tryptophan: a double-blind study versus placebo in cholecystectomized patients. Pain. 1991;47:163–72.
31.
Ekblom A, Hansson P, Thomsson ML. Tryptophan supplementation does not affect postoperative pain intensity or consumption of analgesics. Pain. 1991;44:249–54.CrossRefPubMed
32.
Franklin K, Abbott F, English M, Jeans M, Tasker R, Young S. Tryptophan-morphine interactions and postoperative pain. Pharmacol Biochem Behav. 1990;35:157–63.CrossRefPubMed
33.
Shpeen SE, Morse DR, Furst ML. The effect of tryptophan on postoperative endodontic pain. Oral Surg Oral Med Oral Pathol. 1984;58:446–9.CrossRefPubMed
34.
Amr YM, Yousef AA. Evaluation of efficacy of the perioperative administration of venlafaxine or gabapentin on acute and chronic postmastectomy Pain. Clin J Pain. 2010;26:381–5.CrossRefPubMed
35.
Auerbach AD, Vittinghoff E, Maselli J, Pekow PS, Young JQ, Lindenauer PK. Perioperative use of selective serotonin reuptake inhibitors and risks for adverse outcomes of surgery. JAMA Intern Med. 2013;173:1075–81.CrossRefPubMed
36.
Seitz DP, Bell CM, Gill SS, Reimer CL, Herrmann N, Anderson GM, Newman A, Rochon PA. Risk of perioperative blood transfusions and postoperative complications associated with serotonergic antidepressants in older adults undergoing hip fracture surgery. J Clin Psychopharmacol. 2013;33:790–8.CrossRefPubMed
37.
Weinrieb RM, Auriacombe M, Lynch KG, Lewis JD. Selective serotonin re-uptake inhibitors and the risk of bleeding. Expert Opin Drug Saf. 2005;4:337–44.CrossRefPubMed
38.
Altman CS, Jahangiri MF. Serotonin syndrome in the perioperative period. Anesth Analg. 2010;110:526–8.CrossRefPubMed
39.
Chocron S, Vandel P, Durst C, Laluc F, Kaili D, Chocron M, Etievent JP. Antidepressant therapy in patients undergoing coronary artery bypass grafting: the MOTIV-CABG trial. Ann Thorac Surg. 2013;95:1609–18.CrossRefPubMed
40.
Lunn TH, Frokjaer VG, Hansen TB, Kristensen PW, Lind T, Kehlet H. Analgesic effect of perioperative escitalopram in high pain catastrophizing patients after total knee arthroplasty: a randomized, double-blind, placebo-controlled trial. Anesthesiology. 2015;122(4):884–94.CrossRefPubMed
41.
Gilron I, Kehlet H. Prevention of chronic pain after surgery: new insights for future research and patient care. Can J Anaesth. 2014;61:101–11.CrossRefPubMed
42.
Kalso E. Persistent post-surgery pain: research agenda for mechanisms, prevention, and treatment. Br J Anaesth. 2013;111:9–12.CrossRefPubMed
43.
McGreevy K, Bottros MM, Raja SN. Preventing chronic pain following acute pain: risk factors, preventive strategies, and their efficacy. Eur J Pain Suppl. 2011;5:365–72.PubMedCentralCrossRefPubMed
44.
Obata H, Kimura M, Nakajima K, Tobe M, Nishikawa K, Saito S. Monoamine-dependent, opioid-independent antihypersensitivity effects of intrathecally administered milnacipran, a serotonin noradrenaline reuptake inhibitor, in a postoperative pain model in rats. J Pharmacol Exp Ther. 2010;334:1059–65.CrossRefPubMed
45.
Fais RS, Reis GM, Silveira JW, Dias QM, Rossaneis AC, Prado WA. Amitriptyline prolongs the antihyperalgesic effect of 2- or 100-Hz electro-acupuncture in a rat model of post-incision pain. Eur J Pain. 2012;16:666–75.CrossRefPubMed
46.
Coderre TJ, Katz J, Vaccarino AL, Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain. 1993;52:259–85.CrossRefPubMed
47.
Woolf CJ, Chong MS. Preemptive analgesia—treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg. 1993;77:362–79.CrossRefPubMed
48.
49.
Sipilä R, Estlander AM, Tasmuth T, Kataja M, Kalso E. Development of a screening instrument for risk factors of persistent pain after breast cancer surgery. Br J Cancer. 2012;107:1459–66.PubMedCentralCrossRefPubMed
50.
Althaus A, Hinrichs-Rocker A, Chapman R, Arránz Becker O, Lefering R, Simanski C, Weber F, Moser KH, Joppich R, Trojan S, Gutzeit N, Neugebauer E. Development of a risk index for the prediction of chronic post-surgical pain. Eur J Pain. 2012;16:901–10.CrossRefPubMed
51.
Metadata
Title
Antidepressant Drugs for Postsurgical Pain: Current Status and Future Directions
Author
Ian Gilron
Publication date
01-02-2016
Publisher
Springer International Publishing
Published in
Drugs / Issue 2/2016
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.1007/s40265-015-0517-4

Other articles of this Issue 2/2016

Drugs 2/2016 Go to the issue

Adis Drug Evaluation

Ceftolozane/Tazobactam: A Review in Complicated Intra-Abdominal and Urinary Tract Infections

Leading Article

New Targets in the Drug Treatment of Heart Failure

Adis Drug Evaluation

Dimethyl Fumarate: A Review in Relapsing-Remitting MS

Leading Article

Therapies to Preserve β-Cell Function in Type 1 Diabetes

Therapy in Practice

Diagnosis and Management of Systemic Sclerosis: A Practical Approach

AdisInsight Report

Daratumumab: First Global Approval